Skip to main content

Para operar en EE. UU., ve a polymarket.us

icon for ¿Heidi Overton confirmada como Comisionada de la FDA por...?
Política·Trump

¿Heidi Overton confirmada como Comisionada de la FDA por...?

icon for ¿Heidi Overton confirmada como Comisionada de la FDA por...?
Política·Trump

¿Heidi Overton confirmada como Comisionada de la FDA por...?

$19,662 Vol.

30 sep 2026
Polymarket

$19,662 Vol.

Polymarket

30 de septiembre

$11,104 Vol.

9%

31 de octubre

$4,762 Vol.

45%

30 de noviembre

$1,097 Vol.

44%

31 de diciembre

$2,700 Vol.

55%

This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by October 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by November 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.President Trump's August 2026 nomination of White House domestic policy aide Heidi Overton, a physician with prior roles at the America First Policy Institute, to lead the FDA follows the May resignation of commissioner Marty Makary amid agency turnover and policy clashes. Confirmation requires Senate approval, beginning with the Health, Education, Labor and Pensions Committee. Chair Bill Cassidy has voiced strong concerns about Overton's limited managerial experience and her involvement in recent executive actions on childhood vaccines, signaling potential delays or obstacles in a narrowly Republican-led chamber. Democrats have also raised objections. The FDA continues to manage staffing reductions, morale issues, and ongoing regulatory priorities under acting leadership, with traders monitoring hearing timelines and vote counts for signals on confirmation prospects.

This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.

If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”.

The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution.

The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.
Volumen
$19,662
Fecha de finalización
1 ene 2027
Mercado abierto
Aug 20, 2026, 5:43 PM ET

Resolver

0x65070BE91...
This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by October 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by November 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.President Trump's August 2026 nomination of White House domestic policy aide Heidi Overton, a physician with prior roles at the America First Policy Institute, to lead the FDA follows the May resignation of commissioner Marty Makary amid agency turnover and policy clashes. Confirmation requires Senate approval, beginning with the Health, Education, Labor and Pensions Committee. Chair Bill Cassidy has voiced strong concerns about Overton's limited managerial experience and her involvement in recent executive actions on childhood vaccines, signaling potential delays or obstacles in a narrowly Republican-led chamber. Democrats have also raised objections. The FDA continues to manage staffing reductions, morale issues, and ongoing regulatory priorities under acting leadership, with traders monitoring hearing timelines and vote counts for signals on confirmation prospects.

This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.

If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”.

The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution.

The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.
Volumen
$19,662
Fecha de finalización
1 ene 2027
Mercado abierto
Aug 20, 2026, 5:43 PM ET

Resolver

0x65070BE91...

Relacionado

icon for ¿Será confirmado Hung Cao como Secretario de la Marina antes del 31 de diciembre?

¿Será confirmado Hung Cao como Secretario de la Marina antes del 31 de diciembre?

59%
Sí
icon for ¿Von der Leyen fuera como presidenta de la Comisión Europea en 2026?

¿Von der Leyen fuera como presidenta de la Comisión Europea en 2026?

7%
Sí
icon for ¿Ganará Alexandria Ocasio-Cortez la nominación presidencial demócrata de 2028?

¿Ganará Alexandria Ocasio-Cortez la nominación presidencial demócrata de 2028?

19%
Sí

Cuidado con los enlaces externos.

Preguntas frecuentes

"¿Heidi Overton confirmada como Comisionada de la FDA por...?" es un mercado de predicción en Polymarket con 4 resultados posibles donde los operadores compran y venden acciones según lo que creen que sucederá. El resultado líder actual es "31 de diciembre" con 55%, seguido de "31 de octubre" con 45%. Los precios reflejan probabilidades en tiempo real de la comunidad. Por ejemplo, una acción cotizada a 55¢ implica que el mercado colectivamente asigna una probabilidad de 55% a ese resultado. Estas probabilidades cambian continuamente a medida que los operadores reaccionan a nuevos desarrollos. Las acciones del resultado correcto son canjeables por $1 cada una tras la resolución del mercado.

A día de hoy, "¿Heidi Overton confirmada como Comisionada de la FDA por...?" ha generado $19.7K en volumen total de trading desde que el mercado se lanzó el Aug 20, 2026. Este nivel de actividad refleja un fuerte compromiso de la comunidad de Polymarket y ayuda a garantizar que las probabilidades actuales estén respaldadas por un amplio grupo de participantes del mercado. Puedes seguir los movimientos de precios en vivo y operar en cualquier resultado directamente en esta página.

Para operar en "¿Heidi Overton confirmada como Comisionada de la FDA por...?", explora los 4 resultados disponibles en esta página. Cada resultado muestra un precio actual que representa la probabilidad implícita del mercado. Para tomar una posición, selecciona el resultado que consideres más probable, elige "Sí" para operar a favor o "No" para operar en contra, introduce tu cantidad y haz clic en "Operar". Si tu resultado elegido es correcto cuando el mercado se resuelve, tus acciones de "Sí" pagan $1 cada una. Si es incorrecto, pagan $0. También puedes vender tus acciones en cualquier momento antes de la resolución.

El favorito actual para "¿Heidi Overton confirmada como Comisionada de la FDA por...?" es "31 de diciembre" con 55%, lo que significa que el mercado asigna una probabilidad de 55% a ese resultado. El siguiente resultado más cercano es "31 de octubre" con 45%. Estas probabilidades se actualizan en tiempo real a medida que los operadores compran y venden acciones. Vuelve con frecuencia o guarda esta página en marcadores.

Las reglas de resolución para "¿Heidi Overton confirmada como Comisionada de la FDA por...?" definen exactamente qué debe ocurrir para que cada resultado sea declarado ganador, incluyendo las fuentes de datos oficiales utilizadas para determinar el resultado. Puedes revisar los criterios de resolución completos en la sección "Reglas" en esta página sobre los comentarios. Recomendamos leer las reglas cuidadosamente antes de operar, ya que especifican las condiciones exactas, casos especiales y fuentes.